Literature DB >> 18562239

The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells.

Joe W Ramos1.   

Abstract

The mitogen-activated protein (MAP) kinase extracellular-signal-regulated kinases (ERKs) are activated by diverse mechanisms. These include ligation of receptor tyrosine kinases such as epidermal growth factor (EGF) and cell adhesion receptors such as the integrins. In general, ligand binding of these receptors leads to GTP loading and activation of the small GTPase Ras, which recruits Raf to the membrane where it is activated. Raf subsequently phosphorylates the dual specificity MAP/ERK kinase (MEK1/2) which in turn phosphorylates and thereby activates ERK. ERK is a promiscuous kinase and can phosphorylate more than 100 different substrates. Therefore activation of ERK can affect a broad array of cellular functions including proliferation, survival, apoptosis, motility, transcription, metabolism and differentiation. ERK activity is controlled by many distinct mechanisms. Scaffold proteins control when and where ERK is activated while anchoring proteins can restrain ERK localization to specific subcellular compartments. Meanwhile, phosphatases dephosphorylate and inactivate ERK thereby shutting off the pathway. Finally, several feedback mechanisms have been identified downstream of ERK activation. Here we will focus on the diverse mechanisms of ERK regulation in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562239     DOI: 10.1016/j.biocel.2008.04.009

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  192 in total

1.  MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model.

Authors:  Chandra Bartholomeusz; Tetsuro Oishi; Hitomi Saso; Ugur Akar; Ping Liu; Kimie Kondo; Anna Kazansky; Savitri Krishnamurthy; Jangsoon Lee; Francisco J Esteva; Junzo Kigawa; Naoto T Ueno
Journal:  Mol Cancer Ther       Date:  2011-12-05       Impact factor: 6.261

Review 2.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

3.  Extracellular signal-regulated kinase and GEF-H1 mediate depolarization-induced Rho activation and paracellular permeability increase.

Authors:  Faiza Waheed; Pam Speight; Glenn Kawai; Qinghong Dan; András Kapus; Katalin Szászi
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-17       Impact factor: 4.249

Review 4.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

5.  ERK mediates anti-apoptotic effect through phosphorylation and cytoplasmic localization of p21Waf1/Cip1/Sdi in response to DNA damage in normal human embryonic fibroblast (HEF) cells.

Authors:  Jee-In Heo; Soo-Jin Oh; Yoon-Jung Kho; Jeong-Hyeon Kim; Hong-Joon Kang; Seong-Hoon Park; Hyun-Seok Kim; Jong-Yeon Shin; Min-Ju Kim; Sung Chan Kim; Jae-Bong Park; Jaebong Kim; Jae-Yong Lee
Journal:  Mol Biol Rep       Date:  2010-11-26       Impact factor: 2.316

6.  Scaffolding proteins and non-proliferative functions of ERK1/2.

Authors:  Sarah Appel; Kathleen G Morgan
Journal:  Commun Integr Biol       Date:  2010-07

7.  DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.

Authors:  Wenyan Wang; Hui Wang; Yingying Ni; Zhenming Yao; Liang Ye; Jingwei Tian
Journal:  Tumour Biol       Date:  2016-01-15

8.  Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.

Authors:  Myoungkun Jeoung; Eun Ryoung Jang; Jinpeng Liu; Chi Wang; Eric C Rouchka; Xiaohong Li; Emilia Galperin
Journal:  Cell Signal       Date:  2016-02-11       Impact factor: 4.315

9.  Oral contraceptives and nicotine synergistically exacerbate cerebral ischemic injury in the female brain.

Authors:  Ami P Raval; Raquel Borges-Garcia; Francisca Diaz; Thomas J Sick; Helen Bramlett
Journal:  Transl Stroke Res       Date:  2013-02-13       Impact factor: 6.829

10.  Interaction with Shc prevents aberrant Erk activation in the absence of extracellular stimuli.

Authors:  Kin Man Suen; Chi-Chuan Lin; Roger George; Fernando A Melo; Eleanor R Biggs; Zamal Ahmed; Melanie N Drake; Swathi Arur; Stefan T Arold; John E Ladbury
Journal:  Nat Struct Mol Biol       Date:  2013-04-14       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.